These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Micromethod for determining prekallikrein in blood plasma using a chromogenic substrate]. Kuznetsov VA Lab Delo; 1985; (7):400-2. PubMed ID: 2414517 [No Abstract] [Full Text] [Related]
29. Acetylcysteine in rats: inhibition of activation of prekallikrein and factor XII--protection against dextran-induced blood pressure fall. Hoem NO; Briseid G Pharmacol Toxicol; 1987 Feb; 60(2):140-4. PubMed ID: 2437551 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of activation of the kallikrein-kinin system in plasma of patients with atopic allergic diseases. Dotsenko VL; Nenasheva NM; Neshkova EA; Morozova NA; Yarovaya GA Adv Exp Med Biol; 1989; 247B():515-21. PubMed ID: 2610090 [No Abstract] [Full Text] [Related]
31. Determination of Hageman factor (HG, factor XII) and plasma prekallikrein (Fletcher factor) by radioimmunoassays. Saito H Adv Exp Med Biol; 1979; 120A():165-72. PubMed ID: 573961 [TBL] [Abstract][Full Text] [Related]
32. Studies on assays for plasma prekallikrein and for the monitoring of coumarol therapy. Egberg N; Bergström K Haemostasis; 1978; 7(2-3):85-91. PubMed ID: 149049 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of a microassay for human plasma prekallikrein. De La Cadena RA; Scott CF; Colman RW J Lab Clin Med; 1987 May; 109(5):601-7. PubMed ID: 3646287 [TBL] [Abstract][Full Text] [Related]
34. Determination of prekallikrein in plasma by means of a chromogenic tripeptide substrate for plasma kallikrein. Friberger P; Eriksson E; Gustavsson S; Claeson G Adv Exp Med Biol; 1979; 120A():67-82. PubMed ID: 40406 [TBL] [Abstract][Full Text] [Related]
35. Falls in plasma levels of prekallikrein, high molecular weight kininogen, and kallikrein inhibitors during lethal endotoxin shock in dogs. Gallimore MJ; Aasen AO; Lyngaas KH; Larsbraaten M; Amundsen E Thromb Res; 1978 Feb; 12(2):307-18. PubMed ID: 565085 [No Abstract] [Full Text] [Related]
36. Reduction of contact factors in sickle cell disease. Gordon EM; Klein BL; Berman BW; Strandjord SE; Simon JE; Coccia PF J Pediatr; 1985 Mar; 106(3):427-30. PubMed ID: 3844465 [TBL] [Abstract][Full Text] [Related]
37. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma. Gallimore MJ; Friberger P Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564 [No Abstract] [Full Text] [Related]
38. Direct assay of factor XIIa in plasma with synthetic chromogenic substrates. Kluft C; Svendsen L; Los P Adv Exp Med Biol; 1983; 156():201-4. PubMed ID: 6190367 [No Abstract] [Full Text] [Related]
39. Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase. Claeson G; Friberger P; Knös M; Eriksson E Haemostasis; 1978; 7(2-3):76-8. PubMed ID: 26629 [TBL] [Abstract][Full Text] [Related]
40. [A study of coagulation contact factors in hereditary angioneurotic oedema (author's transl)]. Soulier JP; Gozin D; Ollier-Hartmann MP; Hartmann L Nouv Presse Med; 1981 May; 10(20):1627-31. PubMed ID: 6166918 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]